Concepts (226)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Child Nutrition Disorders | 3 | 2019 | 12 | 1.940 |
Why?
|
| Nutritional Status | 8 | 2020 | 81 | 1.570 |
Why?
|
| Malnutrition | 4 | 2018 | 33 | 1.330 |
Why?
|
| Refeeding Syndrome | 2 | 2019 | 3 | 1.290 |
Why?
|
| Anthropometry | 3 | 2019 | 75 | 1.290 |
Why?
|
| Parenteral Nutrition | 6 | 2024 | 62 | 1.260 |
Why?
|
| Nutrition Assessment | 3 | 2019 | 20 | 1.260 |
Why?
|
| Enteral Nutrition | 7 | 2024 | 105 | 1.110 |
Why?
|
| Micronutrients | 3 | 2019 | 18 | 1.100 |
Why?
|
| Trace Elements | 3 | 2019 | 11 | 1.100 |
Why?
|
| Infant | 18 | 2024 | 3183 | 1.060 |
Why?
|
| Infant, Premature | 3 | 2024 | 298 | 1.040 |
Why?
|
| Gastroenterology | 3 | 2020 | 150 | 0.900 |
Why?
|
| Child | 26 | 2023 | 7216 | 0.870 |
Why?
|
| Short Bowel Syndrome | 4 | 2017 | 38 | 0.830 |
Why?
|
| Enterocolitis, Necrotizing | 2 | 2023 | 80 | 0.830 |
Why?
|
| Child, Preschool | 17 | 2023 | 3765 | 0.820 |
Why?
|
| Cronobacter | 1 | 2022 | 1 | 0.810 |
Why?
|
| Cronobacter sakazakii | 1 | 2022 | 2 | 0.810 |
Why?
|
| Child Development | 3 | 2019 | 167 | 0.780 |
Why?
|
| Hypophosphatemia | 2 | 2019 | 7 | 0.780 |
Why?
|
| Selenium | 1 | 2021 | 46 | 0.750 |
Why?
|
| Exocrine Pancreatic Insufficiency | 2 | 2019 | 8 | 0.730 |
Why?
|
| Vitamins | 2 | 2019 | 83 | 0.720 |
Why?
|
| Hyperglycemia | 2 | 2019 | 173 | 0.690 |
Why?
|
| Intestinal Absorption | 3 | 2009 | 125 | 0.670 |
Why?
|
| Fanconi Syndrome | 1 | 2018 | 3 | 0.610 |
Why?
|
| Glucose | 2 | 2018 | 633 | 0.600 |
Why?
|
| Chromium | 1 | 2017 | 17 | 0.590 |
Why?
|
| Arm | 1 | 2018 | 99 | 0.570 |
Why?
|
| Nutritional Support | 2 | 2017 | 16 | 0.570 |
Why?
|
| Growth | 3 | 2001 | 43 | 0.540 |
Why?
|
| Avitaminosis | 2 | 2019 | 5 | 0.510 |
Why?
|
| Crohn Disease | 4 | 2022 | 765 | 0.480 |
Why?
|
| Food, Formulated | 3 | 2022 | 24 | 0.470 |
Why?
|
| Infant, Newborn | 7 | 2024 | 2501 | 0.470 |
Why?
|
| Humans | 42 | 2024 | 90568 | 0.460 |
Why?
|
| End Stage Liver Disease | 1 | 2013 | 63 | 0.400 |
Why?
|
| Mesalamine | 2 | 2005 | 88 | 0.390 |
Why?
|
| Infant Formula | 3 | 2022 | 17 | 0.380 |
Why?
|
| Failure to Thrive | 2 | 2002 | 17 | 0.370 |
Why?
|
| Diarrhea | 2 | 2018 | 178 | 0.360 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 2 | 2005 | 243 | 0.350 |
Why?
|
| Choline Deficiency | 1 | 2010 | 4 | 0.350 |
Why?
|
| Choline | 1 | 2010 | 24 | 0.340 |
Why?
|
| Malabsorption Syndromes | 1 | 2009 | 21 | 0.340 |
Why?
|
| Digestive System Diseases | 1 | 2009 | 18 | 0.330 |
Why?
|
| Infant, Very Low Birth Weight | 2 | 2021 | 52 | 0.330 |
Why?
|
| Growth Disorders | 2 | 2019 | 63 | 0.330 |
Why?
|
| Vitamin B 12 Deficiency | 1 | 2009 | 7 | 0.330 |
Why?
|
| Methylmalonic Acid | 1 | 2009 | 6 | 0.330 |
Why?
|
| Electrolytes | 2 | 2019 | 52 | 0.320 |
Why?
|
| Intestines | 2 | 2009 | 416 | 0.310 |
Why?
|
| Body Composition | 2 | 2018 | 73 | 0.310 |
Why?
|
| Energy Metabolism | 2 | 2019 | 287 | 0.290 |
Why?
|
| Amino Acids | 3 | 2023 | 249 | 0.290 |
Why?
|
| Reference Values | 2 | 2019 | 662 | 0.290 |
Why?
|
| Drug-Related Side Effects and Adverse Reactions | 1 | 2009 | 203 | 0.280 |
Why?
|
| Probiotics | 1 | 2008 | 88 | 0.270 |
Why?
|
| Adolescent | 13 | 2018 | 9353 | 0.270 |
Why?
|
| Dietary Fats | 2 | 2019 | 135 | 0.260 |
Why?
|
| Hypervitaminosis A | 1 | 2005 | 2 | 0.260 |
Why?
|
| Vitamin A | 1 | 2005 | 28 | 0.250 |
Why?
|
| Feces | 3 | 2019 | 335 | 0.240 |
Why?
|
| Diagnosis, Differential | 5 | 2019 | 1607 | 0.240 |
Why?
|
| Male | 20 | 2023 | 42931 | 0.240 |
Why?
|
| Rehydration Solutions | 1 | 2004 | 4 | 0.240 |
Why?
|
| Dietary Supplements | 1 | 2005 | 124 | 0.240 |
Why?
|
| Dehydration | 1 | 2004 | 20 | 0.240 |
Why?
|
| Milk | 3 | 2020 | 53 | 0.230 |
Why?
|
| Gastroenteritis | 1 | 2004 | 26 | 0.230 |
Why?
|
| Fluid Therapy | 1 | 2004 | 52 | 0.230 |
Why?
|
| Pneumonia | 1 | 2005 | 184 | 0.220 |
Why?
|
| Insulin | 2 | 2019 | 1152 | 0.220 |
Why?
|
| Pancreatic Elastase | 2 | 2019 | 15 | 0.220 |
Why?
|
| Dietary Fiber | 1 | 2023 | 44 | 0.210 |
Why?
|
| Endodermal Sinus Tumor | 1 | 2002 | 3 | 0.200 |
Why?
|
| Female | 20 | 2023 | 46855 | 0.200 |
Why?
|
| Constipation | 2 | 2023 | 67 | 0.200 |
Why?
|
| Liver | 2 | 2023 | 1216 | 0.200 |
Why?
|
| Body Mass Index | 2 | 2018 | 775 | 0.200 |
Why?
|
| Pelvic Neoplasms | 1 | 2002 | 44 | 0.200 |
Why?
|
| Teratoma | 1 | 2002 | 52 | 0.190 |
Why?
|
| Infant, Extremely Low Birth Weight | 1 | 2021 | 26 | 0.190 |
Why?
|
| Pancreas | 2 | 2019 | 253 | 0.190 |
Why?
|
| Powders | 1 | 2022 | 80 | 0.190 |
Why?
|
| Societies | 1 | 2020 | 16 | 0.180 |
Why?
|
| Body Weight | 3 | 2013 | 455 | 0.170 |
Why?
|
| Vitamin D | 1 | 2002 | 269 | 0.170 |
Why?
|
| Nutritional Requirements | 2 | 2013 | 17 | 0.170 |
Why?
|
| Trypsinogen | 1 | 2019 | 4 | 0.170 |
Why?
|
| Magnesium Deficiency | 1 | 2019 | 5 | 0.170 |
Why?
|
| Ectodermal Dysplasia | 1 | 2019 | 2 | 0.170 |
Why?
|
| Enzyme Replacement Therapy | 1 | 2019 | 3 | 0.170 |
Why?
|
| Acyl-CoA Dehydrogenase, Long-Chain | 1 | 2019 | 6 | 0.170 |
Why?
|
| Steatorrhea | 1 | 2019 | 4 | 0.170 |
Why?
|
| Pancreatic Function Tests | 1 | 2019 | 7 | 0.170 |
Why?
|
| Lipid Metabolism, Inborn Errors | 1 | 2019 | 8 | 0.170 |
Why?
|
| Rest | 1 | 2000 | 49 | 0.170 |
Why?
|
| Thiamine Deficiency | 1 | 2019 | 4 | 0.170 |
Why?
|
| Chymotrypsin | 1 | 2019 | 28 | 0.170 |
Why?
|
| Anus, Imperforate | 1 | 2019 | 12 | 0.170 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2022 | 599 | 0.170 |
Why?
|
| Retrospective Studies | 6 | 2021 | 9323 | 0.170 |
Why?
|
| Hypokalemia | 1 | 2019 | 23 | 0.170 |
Why?
|
| Mitochondrial Diseases | 1 | 2019 | 12 | 0.170 |
Why?
|
| Starvation | 1 | 2019 | 23 | 0.170 |
Why?
|
| Pancreatic Diseases | 1 | 2019 | 53 | 0.170 |
Why?
|
| Pain | 1 | 2002 | 399 | 0.160 |
Why?
|
| Muscular Diseases | 1 | 2019 | 64 | 0.160 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2019 | 50 | 0.160 |
Why?
|
| Nose | 1 | 2019 | 95 | 0.160 |
Why?
|
| Pancreatitis, Chronic | 1 | 2019 | 61 | 0.160 |
Why?
|
| Cerebral Palsy | 1 | 2019 | 98 | 0.160 |
Why?
|
| Disability Evaluation | 1 | 2019 | 140 | 0.160 |
Why?
|
| Ehlers-Danlos Syndrome | 1 | 1998 | 8 | 0.160 |
Why?
|
| Enema | 1 | 1998 | 39 | 0.160 |
Why?
|
| Physical Examination | 1 | 2019 | 150 | 0.160 |
Why?
|
| Pericarditis | 1 | 1998 | 15 | 0.160 |
Why?
|
| Cystic Fibrosis | 1 | 2019 | 116 | 0.150 |
Why?
|
| Intestinal Perforation | 1 | 1998 | 36 | 0.150 |
Why?
|
| Aminoglycosides | 1 | 2018 | 33 | 0.150 |
Why?
|
| Drug Hypersensitivity | 1 | 1998 | 37 | 0.150 |
Why?
|
| Intellectual Disability | 1 | 2019 | 188 | 0.150 |
Why?
|
| Sodium | 1 | 2019 | 334 | 0.150 |
Why?
|
| Diet | 2 | 2019 | 447 | 0.150 |
Why?
|
| Urinalysis | 1 | 2018 | 31 | 0.150 |
Why?
|
| Colitis, Ulcerative | 2 | 2022 | 763 | 0.150 |
Why?
|
| Celiac Disease | 1 | 2001 | 215 | 0.150 |
Why?
|
| Aging | 1 | 2002 | 727 | 0.140 |
Why?
|
| Osteoporosis | 1 | 1999 | 122 | 0.140 |
Why?
|
| Metabolic Diseases | 1 | 2018 | 52 | 0.140 |
Why?
|
| World Health Organization | 1 | 2018 | 108 | 0.140 |
Why?
|
| Hypothyroidism | 1 | 2019 | 248 | 0.140 |
Why?
|
| Program Development | 1 | 2017 | 128 | 0.140 |
Why?
|
| Clostridium Infections | 1 | 2018 | 125 | 0.130 |
Why?
|
| United States | 4 | 2024 | 7142 | 0.130 |
Why?
|
| Milk Proteins | 1 | 2016 | 24 | 0.130 |
Why?
|
| Milk Hypersensitivity | 1 | 2016 | 10 | 0.130 |
Why?
|
| Esophagitis | 2 | 2006 | 43 | 0.120 |
Why?
|
| Disease Management | 1 | 2017 | 332 | 0.120 |
Why?
|
| Patient Care Team | 1 | 2017 | 285 | 0.120 |
Why?
|
| Eosinophilia | 2 | 2006 | 85 | 0.120 |
Why?
|
| Birth Weight | 2 | 2016 | 147 | 0.110 |
Why?
|
| Interleukin-12 Receptor beta 1 Subunit | 1 | 2013 | 2 | 0.110 |
Why?
|
| Blood Glucose | 1 | 2017 | 846 | 0.110 |
Why?
|
| Candidiasis | 1 | 2013 | 37 | 0.110 |
Why?
|
| Dietary Proteins | 1 | 2013 | 30 | 0.110 |
Why?
|
| Dietary Carbohydrates | 1 | 2013 | 39 | 0.110 |
Why?
|
| Risk Factors | 2 | 2019 | 5580 | 0.100 |
Why?
|
| Anti-Bacterial Agents | 1 | 2018 | 806 | 0.100 |
Why?
|
| Practice Guidelines as Topic | 2 | 2013 | 1054 | 0.100 |
Why?
|
| HIV Infections | 1 | 2001 | 852 | 0.100 |
Why?
|
| Eosinophilic Esophagitis | 1 | 2011 | 18 | 0.090 |
Why?
|
| Food | 1 | 2011 | 89 | 0.090 |
Why?
|
| Antigens | 1 | 2011 | 229 | 0.090 |
Why?
|
| Body Height | 2 | 2000 | 100 | 0.090 |
Why?
|
| Iatrogenic Disease | 1 | 2009 | 71 | 0.080 |
Why?
|
| Acidosis | 1 | 2009 | 55 | 0.080 |
Why?
|
| Drug Interactions | 1 | 2009 | 244 | 0.080 |
Why?
|
| Drug Administration Schedule | 2 | 2018 | 866 | 0.080 |
Why?
|
| Bacterial Translocation | 1 | 2008 | 26 | 0.070 |
Why?
|
| Gastrointestinal Diseases | 1 | 2009 | 151 | 0.070 |
Why?
|
| Cattle | 2 | 2020 | 379 | 0.070 |
Why?
|
| Prevalence | 2 | 2002 | 1251 | 0.070 |
Why?
|
| Placebos | 1 | 2008 | 211 | 0.070 |
Why?
|
| Recurrence | 3 | 2013 | 1162 | 0.070 |
Why?
|
| Animals | 4 | 2020 | 27691 | 0.070 |
Why?
|
| Cross-Over Studies | 1 | 2008 | 387 | 0.070 |
Why?
|
| Age Factors | 1 | 2010 | 1871 | 0.060 |
Why?
|
| Cross-Sectional Studies | 2 | 2001 | 1735 | 0.060 |
Why?
|
| Osmolar Concentration | 1 | 2004 | 182 | 0.060 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2004 | 73 | 0.060 |
Why?
|
| Adult | 5 | 2013 | 26940 | 0.060 |
Why?
|
| Double-Blind Method | 1 | 2008 | 1726 | 0.050 |
Why?
|
| Galactans | 1 | 2023 | 1 | 0.050 |
Why?
|
| Menarche | 1 | 2022 | 30 | 0.050 |
Why?
|
| Gastrointestinal Tract | 1 | 2004 | 192 | 0.050 |
Why?
|
| Sacrococcygeal Region | 1 | 2002 | 9 | 0.050 |
Why?
|
| Child Nutritional Physiological Phenomena | 1 | 2002 | 12 | 0.050 |
Why?
|
| Vitamin D Deficiency | 1 | 2002 | 104 | 0.050 |
Why?
|
| Anal Canal | 1 | 2002 | 90 | 0.050 |
Why?
|
| Seasons | 1 | 2002 | 242 | 0.050 |
Why?
|
| Perinatology | 1 | 2001 | 14 | 0.050 |
Why?
|
| Peptides | 1 | 2004 | 661 | 0.040 |
Why?
|
| Beverages | 1 | 2020 | 16 | 0.040 |
Why?
|
| Age Determination by Skeleton | 1 | 2000 | 12 | 0.040 |
Why?
|
| Milk, Human | 1 | 2020 | 46 | 0.040 |
Why?
|
| Glucocorticoids | 1 | 2002 | 359 | 0.040 |
Why?
|
| Puberty | 1 | 2000 | 60 | 0.040 |
Why?
|
| Medical Records | 1 | 2000 | 120 | 0.040 |
Why?
|
| Cohort Studies | 2 | 2011 | 2893 | 0.040 |
Why?
|
| Absorptiometry, Photon | 1 | 2000 | 102 | 0.040 |
Why?
|
| Health Education | 1 | 2020 | 105 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2000 | 301 | 0.040 |
Why?
|
| Universities | 1 | 2020 | 147 | 0.040 |
Why?
|
| Diphosphonates | 1 | 1999 | 33 | 0.040 |
Why?
|
| Abdomen, Acute | 1 | 1998 | 20 | 0.040 |
Why?
|
| Sulfasalazine | 1 | 1998 | 34 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 1998 | 298 | 0.040 |
Why?
|
| Prednisone | 1 | 1998 | 254 | 0.040 |
Why?
|
| Bone Density | 1 | 1999 | 211 | 0.040 |
Why?
|
| North America | 1 | 2017 | 188 | 0.040 |
Why?
|
| Sex Factors | 1 | 2000 | 1074 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2018 | 671 | 0.030 |
Why?
|
| Societies, Medical | 1 | 2020 | 591 | 0.030 |
Why?
|
| Protein Hydrolysates | 1 | 2016 | 9 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2005 | 2702 | 0.030 |
Why?
|
| Predictive Value of Tests | 1 | 2000 | 1741 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2000 | 2782 | 0.030 |
Why?
|
| Patient Outcome Assessment | 1 | 2013 | 85 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 2667 | 0.020 |
Why?
|
| Seafood | 1 | 2011 | 10 | 0.020 |
Why?
|
| Eggs | 1 | 2011 | 13 | 0.020 |
Why?
|
| Antigens, Plant | 1 | 2011 | 14 | 0.020 |
Why?
|
| Mucous Membrane | 1 | 2011 | 83 | 0.020 |
Why?
|
| Esophagus | 1 | 2011 | 107 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2018 | 8373 | 0.020 |
Why?
|
| Remission Induction | 1 | 2011 | 745 | 0.020 |
Why?
|
| Biopsy | 1 | 2011 | 1192 | 0.020 |
Why?
|
| Patient Compliance | 1 | 2006 | 230 | 0.010 |
Why?
|
| Esophagoscopy | 1 | 2004 | 90 | 0.010 |
Why?
|
| Gastroesophageal Reflux | 1 | 2004 | 126 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2004 | 1806 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2006 | 3692 | 0.010 |
Why?
|
| Middle Aged | 1 | 2013 | 26327 | 0.010 |
Why?
|